Determining the metabolic profile measured using ultra-high pressure liquid chromatography associated with Beta Amyloid burden in the brain in individuals with mild cognitive impairment
This study analyzes UPLC-based metabolic profiles from 59 individuals with mild cognitive impairment to identify seven specific metabolites, particularly Methionine Sulfoxide, that correlate with beta-amyloid burden and could serve as early biomarkers for Alzheimer's disease progression.